These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34603514)

  • 1. ISCHEMIA Trial: Key Questions and Answers.
    Lopez-Sendon J; Moreno R; Tamargo J
    Eur Cardiol; 2021 Feb; 16():e34. PubMed ID: 34603514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of revascularisation in stable coronary artery disease without ischaemia: a Danish registry-based follow-up study.
    Simonsen JA; Mickley H; Johansen A; Hess S; Thomassen A; Gerke O; Jensen LO; Hallas J; Vach W; Hoilund-Carlsen PF
    BMJ Open; 2017 Aug; 7(8):e016169. PubMed ID: 28801416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design.
    ; Maron DJ; Hochman JS; O'Brien SM; Reynolds HR; Boden WE; Stone GW; Bangalore S; Spertus JA; Mark DB; Alexander KP; Shaw L; Berger JS; Ferguson TB; Williams DO; Harrington RA; Rosenberg Y
    Am Heart J; 2018 Jul; 201():124-135. PubMed ID: 29778671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary revascularisation in patients with ischaemic cardiomyopathy.
    Ryan M; Morgan H; Petrie MC; Perera D
    Heart; 2021 Apr; 107(8):612-618. PubMed ID: 33436491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery stents in the treatment of ischaemic heart disease: a rapid and systematic review.
    Meads C; Cummins C; Jolly K; Stevens A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(23):1-153. PubMed ID: 11074393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants.
    Lancet; 1997 Aug; 350(9076):461-8. PubMed ID: 9274581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial and the appropriateness of revascularization.
    Narayan P
    Indian J Thorac Cardiovasc Surg; 2020 Nov; 36(6):664-667. PubMed ID: 33100632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.
    Ibbotson T; McGavin JK; Goa KL
    Drugs; 2003; 63(11):1121-63. PubMed ID: 12749745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is There Still a Place for Revascularisation in the Management of Stable Coronary Artery Disease Following the ISCHEMIA Trial?
    Gala ABE; Curzen N
    Heart Int; 2020; 14(1):13-15. PubMed ID: 36277662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative Diagnosis of Silent Coronary Ischaemia May Reduce Post-operative Death and Myocardial Infarction and Improve Survival of Patients Undergoing Lower Extremity Surgical Revascularisation.
    Krievins D; Zellans E; Latkovskis G; Erglis A; Zvaigzne L; Kumsars I; Rumba R; Stradins P; Jegere S; Zarins CK
    Eur J Vasc Endovasc Surg; 2020 Sep; 60(3):411-420. PubMed ID: 32709470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISCHEMIA Trial and the Significance of MI.
    Arias EA; Damas-de Los Santos F; Ontiveros-Mercado H
    Interv Cardiol; 2020 Apr; 15():e14. PubMed ID: 33163087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques and approaches for revascularisation of left heart coronary diseases.
    Maskell P; Oo S; Muir AD; Fan KS; Harky A
    Br J Hosp Med (Lond); 2020 Aug; 81(8):1-11. PubMed ID: 32845756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal medical therapy for coronary artery disease in 2011 - perspectives from the STICH Trial.
    Whayne TF; Saha SP; Quevedo K; Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):269-76. PubMed ID: 21902655
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.